Back
Cognition Therapeutics Stock Price Chart
Sold-out (twice) tech raise for accredited investors only
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Sell
20
CGTX
Cognition Therapeutics
Last Price:
$0.31
Seasonality Move:
-40.23%
7 Day Trial
ALL ACCESS PASS
$
7
Big exits started like this. So did Mode
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite-
The current trend is relatively stagnant and CGTX is experiencing selling pressure, which indicates risk of future bearish movement.
Cognition Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.28 | Sell |
| 20-day SMA: | 0.32 | Sell |
| 50-day SMA: | 0.37 | Sell |
| 200-day SMA: | 0.51 | Sell |
| 8-day EMA: | 0.27 | Sell |
| 20-day EMA: | 0.31 | Sell |
| 50-day EMA: | 0.37 | Sell |
| 200-day EMA: | 0.65 | Sell |
Cognition Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 28.5 | Sell |
| Chaikin Money Flow: | -392339 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.28 - 0.42) | Sell |
| Bollinger Bands (100): | (0.33 - 0.65) | Sell |
Cognition Therapeutics Technical Analysis
| May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cognition Therapeutics Stock
Is Cognition Therapeutics Stock a Buy?
-
Cognition Therapeutics share price is 0.24 while CGTX 8-day simple moving average is 0.28, which is a Sell signal.
-
The stock price of CGTX is 0.24 while Cognition Therapeutics 20-day SMA is 0.32, which makes it a Sell.
-
Cognition Therapeutics 50-day simple moving average is 0.37 while CGTX share price is 0.24, making it a Sell technically.
-
CGTX stock price is 0.24 and Cognition Therapeutics 200-day simple moving average is 0.51, creating a Sell signal.
CGTX Technical Analysis vs Fundamental Analysis
Sell
20
Cognition Therapeutics (CGTX)
is a Sell
Is Cognition Therapeutics a Buy or a Sell?
-
Cognition Therapeutics stock is rated a SellThe current Cognition Therapeutics [CGTX] share price is $0.24. The Score for CGTX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Cognition Therapeutics Stock Info
Market Cap:
14.8M
Price in USD:
0.24
Share Volume:
642.6K
Cognition Therapeutics 52-Week Range
52-Week High:
2.54
52-Week Low:
0.22
Sell
20
Cognition Therapeutics (CGTX)
is a Sell
Cognition Therapeutics Share Price Forecast
-
What is the Cognition Therapeutics stock price today?The Cognition Therapeutics stock price is 0.24 USD today.
-
Will CGTX stock go up or go down?Cognition Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cognition Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cognition Therapeutics is overvalued.
Is Cognition Therapeutics Stock a Buy?
-
Cognition Therapeutics share price is 0.24 while CGTX 8-day exponential moving average is 0.27, which is a Sell signal.
-
The stock price of CGTX is 0.24 while Cognition Therapeutics 20-day EMA is 0.31, which makes it a Sell.
-
Cognition Therapeutics 50-day exponential moving average is 0.37 while CGTX share price is 0.24, making it a Sell technically.
-
CGTX stock price is 0.24 and Cognition Therapeutics 200-day simple moving average is 0.65, creating a Sell signal.
Fundamental Analysis of Cognition Therapeutics
Is Cognition Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.04 per share, an increase this year of $0.38 per share, and an increase next year of $0.13 per share.
Technical Analysis of Cognition Therapeutics
Should I short Cognition Therapeutics stock?
-
CGTX Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Cognition Therapeutics is a Sell
-
Cognition Therapeutics Relative Strength Index (RSI) is 28.5, which suggest Cognition Therapeutics is oversold
-
The Bollinger Bands (25) for Cognition Therapeutics is (0.28 - 0.42), which suggest Cognition Therapeutics is a Sell
-
The Bollinger Bands (100) for Cognition Therapeutics is (0.33 - 0.65), which suggest Cognition Therapeutics is a Sell
* Cognition Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.